Phase I dose-finding study of OPB-111077, a novel STAT3 inhibitor, in patients with advanced hepatocellular carcinoma.
暂无分享,去创建一个
Myung Ah Lee | Tae-You Kim | H. Lim | J. Kim | B. Ryoo | Jihoon Kang | Kyu-pyo Kim | C. Yoo
暂无分享,去创建一个
Myung Ah Lee | Tae-You Kim | H. Lim | J. Kim | B. Ryoo | Jihoon Kang | Kyu-pyo Kim | C. Yoo